[HKU Medical Grand Rounds] Angels and demons: Immunotherapy for treatment of advanced hepatocellular carcinoma
22 Jul 2024
byDr. Bryan Li
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Dr. Gerry Kwok
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Dr. Thomas Yau
Department of Medicine
The University of Hong Kong
Case 1: A 59-year-old gentleman with advanced HCC was referred to our centre for management. He had a history of diabetes, hypertension and ischaemic heart disease. He was a nondrinker and not a carrier of hepatitis B or C.
Case 2: A 65-year-old man with a history of alcoholic cirrhosis and oesophageal varices was found to have rising AFP levels on routine follow-up. He also had a 3-year history of diabetes and was on diet control, with an HbA1c of 6.2 percent and fasting glucose of 6.8 mmol/L. He did not need any diabetic medications.